Past. With obviously the oil market. Everybody knows goes through ups and downs and peaks and valleys and so in the last few years we have the resources. We build the resources. We build the buffers to help us in sustaining our policies and not disrupting them. So im comfortable well be able to continue that. Hes comfortable but a lot of other people arent. Oil prices are now down about 60 since mid june but that doesnt tell the story of the last week. Over the hastlast week oil prices pick up about 20 . Youre talking about wild swings. A lot of people that rely on oil say they have a tougher time with the massive swings in oil prices. Well be talking more about crude oil in a few minutes. First we have other stories to watch this morning. Heres whats happening. A flood of economic data. Weekly jobless claims. International trade and productive and costs. All of those reports due at 8 30 eastern time and michael kors sirius xm and this afternoon go pro linkedin twitter, yelp pandora, a
The senate acts . And which companies could benefit big time. All that and more tonight on nightly Business Report for monday, november 17th. Good evening, everyone. A big day for big deals today. The buzz on wall street was all about two blockbuster mergers, one in the Energy Sector. Well have more on that in a moment. The other in the health care sector. We begin with the bigger of the two deals, generic drugmaker actavis agreeing to pay 66 billion for allergan, the maker of botox. The massive price tag which amounts to 219 per share effectively ends a monthlong hostile bid by Hedge Fund Manager bill ackman along with canadian drugmaker valeant for the same company. Investors approved. Shares of actavis rose while allergan jumped 5 . More now on how actavis sealed the deal. The bidding war for botoxmaker allergan didnt end up quite the way actavis investor bill ackman had been hoping for. More potential partners or combination partners say theyre not interested in allergan puts valea
What will the president do if the senate acts . And which companies could benefit big time. All that and more tonight on nightly Business Report for monday, november 17th. Good evening, everyone. A big day for big deals today. The buzz on wall street was all about two blockbuster mergers, one in the Energy Sector. Well have more on that in a moment. The other in the health care sector. We begin with the bigger of the two deals, generic drugmaker actavis agreeing to pay 66 billion for allergan, the maker of botox. The massive price tag which amounts to 219 per share effectively ends a monthlong hostile bid by Hedge Fund Manager bill ackman along with canadian drugmaker valeant for the same company. Investors approved. Shares of actavis rose while allergan jumped 5 . More now on how actavis sealed the deal. The bidding war for botoxmaker allergan didnt end up quite the way actavis investor bill ackman had been hoping for. More potential partners or combination partners say theyre not int
What will the president do if the senate acts . And which companies could benefit big time. All that and more tonight on nightly Business Report for monday, november 17th. Good evening, everyone. A big day for big deals today. The buzz on wall street was all about two blockbuster mergers, one in the Energy Sector. Well have more on that in a moment. The other in the health care sector. We begin with the bigger of the two deals, generic drugmaker actavis agreeing to pay 66 billion for allergan, the maker of botox. The massive price tag which amounts to 219 per share effectively ends a monthlong hostile bid by Hedge Fund Manager bill ackman along with canadian drugmaker valeant for the same company. Investors approved. Shares of actavis rose while allergan jumped 5 . More now on how actavis sealed the deal. The bidding war for botoxmaker allergan didnt end up quite the way actavis investor bill ackman had been hoping for. More potential partners or combination partners say theyre not int